Logo image of AXON

AXON ENTERPRISE INC (AXON) Stock Fundamental Analysis

USA - NASDAQ:AXON - US05464C1018 - Common Stock

750.67 USD
-10.12 (-1.33%)
Last: 9/16/2025, 8:00:01 PM
751.07 USD
+0.4 (+0.05%)
After Hours: 9/16/2025, 8:00:01 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AXON. AXON was compared to 69 industry peers in the Aerospace & Defense industry. Both the profitability and the financial health of AXON get a neutral evaluation. Nothing too spectacular is happening here. AXON is valued quite expensive, but it does show an excellent growth. These ratings could make AXON a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year AXON was profitable.
AXON had a positive operating cash flow in the past year.
In multiple years AXON reported negative net income over the last 5 years.
AXON had a positive operating cash flow in each of the past 5 years.
AXON Yearly Net Income VS EBIT VS OCF VS FCFAXON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

With a decent Return On Assets value of 5.25%, AXON is doing good in the industry, outperforming 71.01% of the companies in the same industry.
AXON's Return On Equity of 11.94% is fine compared to the rest of the industry. AXON outperforms 79.71% of its industry peers.
Industry RankSector Rank
ROA 5.25%
ROE 11.94%
ROIC N/A
ROA(3y)6.24%
ROA(5y)3.01%
ROE(3y)12.89%
ROE(5y)6.55%
ROIC(3y)N/A
ROIC(5y)N/A
AXON Yearly ROA, ROE, ROICAXON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

AXON has a Profit Margin of 13.64%. This is amongst the best in the industry. AXON outperforms 88.41% of its industry peers.
AXON's Profit Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 60.47%, AXON belongs to the top of the industry, outperforming 91.30% of the companies in the same industry.
In the last couple of years the Gross Margin of AXON has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 13.64%
GM 60.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y155.54%
GM growth 3Y-1.64%
GM growth 5Y0.59%
AXON Yearly Profit, Operating, Gross MarginsAXON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

6

2. Health

2.1 Basic Checks

AXON does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AXON has been increased compared to 1 year ago.
AXON has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AXON has an improved debt to assets ratio.
AXON Yearly Shares OutstandingAXON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AXON Yearly Total Debt VS Total AssetsAXON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

AXON has an Altman-Z score of 11.37. This indicates that AXON is financially healthy and has little risk of bankruptcy at the moment.
AXON has a Altman-Z score of 11.37. This is amongst the best in the industry. AXON outperforms 88.41% of its industry peers.
AXON has a debt to FCF ratio of 11.38. This is a negative value and a sign of low solvency as AXON would need 11.38 years to pay back of all of its debts.
AXON has a Debt to FCF ratio (11.38) which is in line with its industry peers.
A Debt/Equity ratio of 0.63 indicates that AXON is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, AXON is not doing good in the industry: 62.32% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.38
Altman-Z 11.37
ROIC/WACCN/A
WACC9.64%
AXON Yearly LT Debt VS Equity VS FCFAXON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.95 indicates that AXON has no problem at all paying its short term obligations.
AXON has a better Current ratio (2.95) than 63.77% of its industry peers.
A Quick Ratio of 2.71 indicates that AXON has no problem at all paying its short term obligations.
AXON has a better Quick ratio (2.71) than 82.61% of its industry peers.
Industry RankSector Rank
Current Ratio 2.95
Quick Ratio 2.71
AXON Yearly Current Assets VS Current LiabilitesAXON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

8

3. Growth

3.1 Past

AXON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.24%, which is quite impressive.
The Earnings Per Share has been growing by 41.41% on average over the past years. This is a very strong growth
Looking at the last year, AXON shows a very strong growth in Revenue. The Revenue has grown by 32.37%.
AXON shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.44% yearly.
EPS 1Y (TTM)57.24%
EPS 3Y36.34%
EPS 5Y41.41%
EPS Q2Q%76.67%
Revenue 1Y (TTM)32.37%
Revenue growth 3Y34.11%
Revenue growth 5Y31.44%
Sales Q2Q%32.62%

3.2 Future

AXON is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.51% yearly.
AXON is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.50% yearly.
EPS Next Y16.3%
EPS Next 2Y17.2%
EPS Next 3Y19.51%
EPS Next 5YN/A
Revenue Next Year30.95%
Revenue Next 2Y27.6%
Revenue Next 3Y25.4%
Revenue Next 5Y19.5%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AXON Yearly Revenue VS EstimatesAXON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
AXON Yearly EPS VS EstimatesAXON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 106.33, which means the current valuation is very expensive for AXON.
AXON's Price/Earnings ratio is in line with the industry average.
AXON's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.20.
The Price/Forward Earnings ratio is 92.94, which means the current valuation is very expensive for AXON.
62.32% of the companies in the same industry are cheaper than AXON, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.71. AXON is valued rather expensively when compared to this.
Industry RankSector Rank
PE 106.33
Fwd PE 92.94
AXON Price Earnings VS Forward Price EarningsAXON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

65.22% of the companies in the same industry are cheaper than AXON, based on the Enterprise Value to EBITDA ratio.
AXON's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 333.89
EV/EBITDA 975
AXON Per share dataAXON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AXON does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as AXON's earnings are expected to grow with 19.51% in the coming years.
PEG (NY)6.52
PEG (5Y)2.57
EPS Next 2Y17.2%
EPS Next 3Y19.51%

0

5. Dividend

5.1 Amount

No dividends for AXON!.
Industry RankSector Rank
Dividend Yield N/A

AXON ENTERPRISE INC

NASDAQ:AXON (9/16/2025, 8:00:01 PM)

After market: 751.07 +0.4 (+0.05%)

750.67

-10.12 (-1.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners81.96%
Inst Owner ChangeN/A
Ins Owners0.57%
Ins Owner Change5.24%
Market Cap58.93B
Analysts83.08
Price Target885.54 (17.97%)
Short Float %2.19%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.34%
Min EPS beat(2)8.51%
Max EPS beat(2)42.17%
EPS beat(4)4
Avg EPS beat(4)28.65%
Min EPS beat(4)8.51%
Max EPS beat(4)45.27%
EPS beat(8)8
Avg EPS beat(8)26.23%
EPS beat(12)12
Avg EPS beat(12)33.52%
EPS beat(16)16
Avg EPS beat(16)60.63%
Revenue beat(2)2
Avg Revenue beat(2)2.58%
Min Revenue beat(2)1.38%
Max Revenue beat(2)3.78%
Revenue beat(4)3
Avg Revenue beat(4)1.6%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)3.78%
Revenue beat(8)7
Avg Revenue beat(8)2.04%
Revenue beat(12)11
Avg Revenue beat(12)3.55%
Revenue beat(16)15
Avg Revenue beat(16)4.85%
PT rev (1m)9.21%
PT rev (3m)22.37%
EPS NQ rev (1m)1.87%
EPS NQ rev (3m)-1.39%
EPS NY rev (1m)8.39%
EPS NY rev (3m)9.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.18%
Revenue NY rev (1m)2.1%
Revenue NY rev (3m)2.25%
Valuation
Industry RankSector Rank
PE 106.33
Fwd PE 92.94
P/S 24.64
P/FCF 333.89
P/OCF 213.83
P/B 21.57
P/tB 32.6
EV/EBITDA 975
EPS(TTM)7.06
EY0.94%
EPS(NY)8.08
Fwd EY1.08%
FCF(TTM)2.25
FCFY0.3%
OCF(TTM)3.51
OCFY0.47%
SpS30.47
BVpS34.81
TBVpS23.03
PEG (NY)6.52
PEG (5Y)2.57
Profitability
Industry RankSector Rank
ROA 5.25%
ROE 11.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 13.64%
GM 60.47%
FCFM 7.38%
ROA(3y)6.24%
ROA(5y)3.01%
ROE(3y)12.89%
ROE(5y)6.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.99%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y155.54%
GM growth 3Y-1.64%
GM growth 5Y0.59%
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.38
Debt/EBITDA 29.12
Cap/Depr 163.86%
Cap/Sales 4.14%
Interest Coverage N/A
Cash Conversion 464.18%
Profit Quality 54.09%
Current Ratio 2.95
Quick Ratio 2.71
Altman-Z 11.37
F-Score4
WACC9.64%
ROIC/WACCN/A
Cap/Depr(3y)192.5%
Cap/Depr(5y)286.11%
Cap/Sales(3y)4.12%
Cap/Sales(5y)5.78%
Profit Quality(3y)94.26%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.24%
EPS 3Y36.34%
EPS 5Y41.41%
EPS Q2Q%76.67%
EPS Next Y16.3%
EPS Next 2Y17.2%
EPS Next 3Y19.51%
EPS Next 5YN/A
Revenue 1Y (TTM)32.37%
Revenue growth 3Y34.11%
Revenue growth 5Y31.44%
Sales Q2Q%32.62%
Revenue Next Year30.95%
Revenue Next 2Y27.6%
Revenue Next 3Y25.4%
Revenue Next 5Y19.5%
EBIT growth 1Y-100.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.57%
EBIT Next 3Y48.75%
EBIT Next 5YN/A
FCF growth 1Y59.92%
FCF growth 3Y64.36%
FCF growth 5Y46.2%
OCF growth 1Y74.03%
OCF growth 3Y48.58%
OCF growth 5Y44.12%